CVS Health Q3 2026: Aetna's turnaround drives a 27% EPS beat

CVS Health reported adjusted earnings per share of $2.09 for the third quarter of 2026, clearing the Wall Street consensus of $1.65 by 26.61%. That marked the sixth consecutive quarter in which the company topped EPS expectations, a streak that has reset how analysts and investors are thinking about the reliability of CVS's earnings.

The headline driver was a sharp recovery inside the Health Care Benefits segment. Aetna's medical benefit ratio improved to 91.3% from 92.8% a year earlier, meaning the insurer spent a smaller share of premium revenue on medical claims. That improvement helped push Health Care Benefits adjusted operating income to $912 million, up from $314 million in the same period last year.

Revenue came in at $108.40 billion, a gain of roughly 5.4% year over year and a beat of 3.54% against the $104.69 billion consensus. The Health Services segment was the fastest-growing unit, with revenue up 9.5%, while Pharmacy and Consumer Wellness adjusted operating income rose 10.6%, supported in part by prescription file acquisitions from Rite Aid. The only soft spot was Pharmacy and Consumer Wellness revenue, which slipped 2.0%, and commercial premiums, which declined 16.9% following the company's exit from the individual exchange business.

Management responded to the stronger results by raising full-year 2026 adjusted EPS guidance to at least $8.20, up from a prior range of $7.90 to $8.10. The company also lifted its operating cash flow target to at least $15.5 billion from at least $11.5 billion previously. Those are meaningful revisions, and they suggest leadership has gained confidence in the trajectory of medical cost trends even as it cautioned that elevated costs and macro headwinds remain live risks for the rest of the year.

Reports of a corporate breakup into two publicly traded companies added a strategic dimension to the quarter that the results alone do not resolve. For now, the numbers point to a business stabilizing after a prolonged stretch of managed-care turbulence, with Aetna's cost improvement and six straight EPS beats providing the clearest evidence of that turn.